Tech Company Financing Transactions
Kinex Pharmaceuticals Funding Round
Kinex Pharmaceuticals closed a funding round on 10/22/2012. Backers included Pharminex.
Transaction Overview
Company Name
Announced On
10/22/2012
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Pharminex (Chuck Lannon)
Proceeds Purpose
The funds will be used to advance the Company's multiple clinical development programs.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
701 Ellicott St.
Buffalo, NY 14203
USA
Buffalo, NY 14203
USA
Phone
Website
Email Address
Overview
Kinex is a specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Johnson Lau
Chief Medical Officer
Rudolf Kwan
Chief Operating Officer
Flint Besecker
Chief Scientific Officer
David Hangauer
Browse more venture capital transactions:
Prev: 10/22/2012: Intelli-Touch Apps venture capital transaction
Next: 10/22/2012: Gigwalk venture capital transaction
Share this article
News on VC Transactions
We do our best to record every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs